Showing results (831-840 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|July 27, 2014
Role of cognitive enhancer therapy in Alzheimer's disease with concomitant cerebral white matter disease: findings from a long-term naturalistic studyKok Pin Ng, Aloysius Ng, Pryseley Assam, et al.Drugs in R&D|September 20, 2013
N-Acetylcysteine effects on transforming growth factor-β and tumor necrosis factor-α serum levels as pro-fibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarctionAzita Hajhossein Talasaz, Hossein Khalili, Yaser Jenab, et al.Drugs in R&D|April 23, 2013
Efficacy and safety of a fixed combination of irbesartan/hydrochlorothiazide in Chinese patients with moderate to severe hypertensionQi-Fang Huang, Chang-Sheng Sheng, Yan Li, et al.Drugs in R&D|March 19, 2026
Pharmacokinetics and Bioequivalence Evaluation of Piracetam Tablet: A Randomized, Single-Dose, Two-Period, Crossover Study in Healthy Chinese Participants Under Fasting and Fed ConditionsHegui Yan, Ming Zhou, Zhixiang Pan, et al.Drugs in R&D|June 2, 2023
N-Acetyl-L-Cysteine Reduces Cervical Carcinogenesis by Promoting ApoptosisWenping Guo, Wang JingDrugs in R&D|May 29, 2023
A Randomized, Double-Blind, Parallel-Controlled Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of SCT510 to Bevacizumab (Avastin®) in Healthy Chinese MalesJing Wu, Guolan Wu, Liangzhi Xie, et al.Drugs in R&D|May 24, 2026
A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine TumorsJavier Molina-Cerrillo, Arantzazu Sierra-Ramirez, José L López-Aceituno, et al.Drugs in R&D|March 12, 2026
Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of LornoxicamYang Liu, Qiong-Zhi Shi, Yanchen Wang, et al.Drugs in R&D|June 21, 2006
Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in ratsM L Arruzazabala, R Más, V Molina, et al.Drugs in R&D|November 1, 2016
Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight ChangesEiji Kutoh, Teruma Murayama, Asuka Wada, et al.Pageof 89